RMC-6236 + gemcitabine and nab-paclitaxel for pancreatic cancer (RMC-GI-102_C)

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
[RMC-GI-102 C&F] A Platform Study of RAS(ON) Inhibitors in Patients with Gastrointestinal Solid Tumors
Principal Investigator
Headshot of John Strickler
Professor of Medicine
Protocol Number
IRB: PRO00115670
NCT: NCT06445062
Phase
Phase I/II
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL
Participate